Jo Walton

Stock Analyst at UBS

(n/a)

# 4,827

Out of 5,178 analysts

2

Total ratings

n/a

Success rate

-33.17%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General

Stocks Rated by Jo Walton

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NVO Novo Nordisk	Upgrades: Buy	n/a	$36.40	-	1	Jan 8, 2025
	GSK GSK plc	Downgrades: Neutral	n/a	$53.94	-	1	Jul 8, 2024

Novo Nordisk

Jan 8, 2025

Upgrades: Buy

Price Target: n/a

Current: $36.40

Upside: -

GSK plc

Jul 8, 2024

Downgrades: Neutral

Price Target: n/a

Current: $53.94

Upside: -